William T. Andrews, M.D., FACP
2019
In 2019, William T. Andrews, M.D., FACP earned a total compensation of $1.1M as Former Chief Medical Officer at Opexa Therapeutics, a 115% increase compared to previous year.
Compensation breakdown
| Option Awards | $462,041 |
|---|---|
| Salary | $412,000 |
| Stock Awards | $212,400 |
| Total | $1,086,441 |
FACP received $462K in option awards, accounting for 43% of the total pay in 2019.
FACP also received $412K in salary and $212.4K in stock awards.
Rankings
In 2019, William T. Andrews, M.D., FACP's compensation ranked 8,902nd out of 13,971 executives tracked by ExecPay. In other words, FACP earned more than 36.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,902 out of 13,971 | 36th |
Division Manufacturing | 3,554 out of 5,695 | 38th |
Major group Chemicals And Allied Products | 1,341 out of 2,194 | 39th |
Industry group Drugs | 1,142 out of 1,880 | 39th |
Industry Pharmaceutical Preparations | 845 out of 1,392 | 39th |
Source: SEC filing on October 14, 2020.
FACP's colleagues
We found two more compensation records of executives who worked with William T. Andrews, M.D., FACP at Opexa Therapeutics in 2019.